Novartis
NVS
1,313 hedge funds and large institutions have $15.2B invested in Novartis in 2024 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 414 increasing their positions, 484 reducing their positions, and 77 closing their positions.
5% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 77
0% more funds holding
Funds holding: 1,307 → 1,313 (+6)
0.23% less ownership
Funds ownership: 6.74% → 6.52% (-0.23%)
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
14% less repeat investments, than reductions
Existing positions increased: 414 | Existing positions reduced: 484
42% less call options, than puts
Call options by funds: $171M | Put options by funds: $294M
53% less capital inflows, than outflows
Capital inflows: $554M | Capital outflows: $1.18B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$77.8M |
| 2 |
Goldman Sachs
New York
|
+$46M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$30.5M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$26.3M |
| 5 |
Mediolanum International Funds
Dublin 1,
Ireland
|
+$23.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Magnetar Financial
Evanston,
Illinois
|
-$139M |
| 2 |
Bank of New York Mellon
New York
|
-$130M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$109M |
| 4 |
Cullen Capital Management
New York
|
-$70.2M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$64.6M |
NVS Hedge Fund Activity: Q3 2024 in Review
1,313 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2024, worth a combined $15.2B — up 3.7% from $14.7B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new NVS positions and 77 closed out — a net gain of 4 holders — while 414 added to existing stakes and 484 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $77.8M. The largest seller was Magnetar Financial, exiting entirely with an estimated $139M sold.
- 1,313 institutional investors held Novartis (NVS) as of Q3 2024, up from 1,307 in Q2 2024.
- Funds reported $15.2B of Novartis stock for Q3 2024, up 3.7% quarter-over-quarter.
- 81 funds opened new Novartis positions in Q3 2024 and 77 closed out, a net change of +4 holders.
- The largest Novartis buyer in Q3 2024 was Dimensional Fund Advisors, an estimated $77.8M added.
- The largest Novartis seller in Q3 2024 was Magnetar Financial, an estimated $139M sold.
Based on aggregated 13F filings for Q3 2024.